
The White House has withdrawn Dr. Heidi Overton’s nomination for FDA commissioner just a day before a Senate committee vote.
Click the title above to open the Pharmaceutical Executive August 2018 issue in an interactive PDF format.
about 8 years ago
Emerging Biotech: Innovation, Location, and Inspirationabout 8 years ago
Cross-Border Funding in the Life Sciencesover 8 years ago
Face It. You’re Not a Biotech Anymoreover 8 years ago
The Pulse of Biopharma M&Aover 8 years ago
The Big Apple’s Fresh Start in Biotechover 8 years ago
‘Emerging’ Product Launch Strategiesover 8 years ago
Biotech Investment: Reigning in Spainover 8 years ago
Traditional Scientific Search is Brokenover 8 years ago
Tough Fight Looms in Preserving R&D Incentivesover 8 years ago
From Science to Success




